We are live on ! Find out more
TCSAM

Tyrus Capital S.A.M. Portfolio holdings

AUM $10.5M
1-Year Est. Return 4.88%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
-4.88%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$83.3M
Cap. Flow
-$93.8M
Cap. Flow %
-35.78%
Top 10 Hldgs %
99.18%
Holding
21
New
7
Increased
3
Reduced
1
Closed
10

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$75.3M
2
AAL icon
American Airlines Group
AAL
+$24.5M
3
TLM
TALISMAN ENERGY INC
TLM
+$20.4M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.7M
5
SONY icon
Sony
SONY
+$19.5M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$63.1M
2
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$55.3M
3
AAPL icon
Apple
AAPL
+$47.7M
4
YPF icon
YPF
YPF
+$42.6M
5
DF
Dean Foods Company
DF
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 40.4%
2 Technology 22.62%
3 Energy 9.42%
4 Industrials 9.15%
5 Consumer Discretionary 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$85.9M 32.76%
2,955,073
+2,586,173
+701% +$75.3M
ATVI
2
DELISTED
Activision Blizzard
ATVI
$41M 15.64%
2,300,000
+525,000
+30% +$9.03M
AAL icon
3
American Airlines Group
AAL
$9.82B
$24M 9.15%
+950,000
New +$24.5M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$40.4B
$20M 7.64%
+500,000
New +$19.7M
TLM
5
DELISTED
TALISMAN ENERGY INC
TLM
$19.7M 7.53%
+1,695,000
New +$20.4M
CTRX
6
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$19.5M 7.44%
410,700
+225,700
+122% +$10.6M
SONY icon
7
Sony
SONY
$137B
$18.3M 6.98%
+5,290,000
New +$19.5M
ULTA icon
8
Ulta Beauty
ULTA
$21.8B
$15.3M 5.82%
+158,000
New +$18.5M
FNF icon
9
Fidelity National Financial
FNF
$14.4B
$11.4M 4.33%
+613,034
New +$9.92M
YPF icon
10
YPF
YPF
$19.7B
$4.94M 1.89%
150,000
-1,663,000
-92% -$42.6M
TIMB icon
11
TIM SA
TIMB
$9.1B
$2.15M 0.82%
+82,000
New +$2.07M
AAPL icon
12
Apple
AAPL
$4.97T
– –
-2,802,100
Closed -$47.7M
ANF icon
13
Abercrombie & Fitch
ANF
$4.55B
– –
-60,000
Closed -$2.12M
BHC icon
14
Bausch Health
BHC
$1.75B
– –
-605,000
Closed -$63.1M
KO icon
15
Coca-Cola
KO
$383B
– –
-215,000
Closed -$8.14M
RL icon
16
Ralph Lauren
RL
$22.4B
– –
-110,000
Closed -$18.1M
T icon
17
AT&T
T
$164B
– –
-847,360
Closed -$21.6M
CBD
18
DELISTED
Companhia Brasileira de Distribuicao
CBD
– –
-150,000
Closed -$6.9M
DF
19
DELISTED
Dean Foods Company
DF
– –
-1,177,500
Closed -$22.7M
TFCFA
20
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-1,650,000
Closed -$55.3M
TWX
21
DELISTED
Time Warner Inc
TWX
– –
-237,283
Closed -$15M

Similar funds

PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
EEPIS
Evolution Equity Partners II SARL Luxembourg $11.8M AUM 63.6% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return
MM
Malka Meyer $8.77M AUM 64.77% 1-Year Est. Return
PGEBT
Pactiv General Employee Benefit Trust Lake Forest, Illinois $8.68M AUM 0.77% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
WCH
Willoughby Capital Holdings Greenwich, Connecticut $7.65M AUM 39.76% 1-Year Est. Return

Tyrus Capital S.A.M.'s Q4 2013 Portfolio in Review

As of Q4 2013, Tyrus Capital S.A.M. held 21 positions worth $262M, down 24% from $345M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Tyrus Capital S.A.M. withdrew a net $93.8M in Q4 2013, closing 10 positions and reducing 1 holding. Its most notable exit was Bausch Health, an estimated $63.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

Against the trend, Tyrus Capital S.A.M. opened a new position in American Airlines Group worth $24M.

  • Tyrus Capital S.A.M.'s largest Q4 2013 buy was American Airlines Group: 950,000 shares worth $24M.
  • Tyrus Capital S.A.M. added most to Pfizer in Q4 2013, an estimated $75.3M increase.
  • Tyrus Capital S.A.M.'s biggest Q4 2013 reduction was YPF, cutting an estimated $42.6M.
  • Tyrus Capital S.A.M. fully exited Bausch Health in Q4 2013, selling an estimated $63.1M.
  • Tyrus Capital S.A.M.'s ten largest holdings make up 99% of its $262M portfolio in Q4 2013.
  • Tyrus Capital S.A.M. opened 7 new positions and closed 10 in Q4 2013.
  • Tyrus Capital S.A.M.'s portfolio value fell 24% quarter-over-quarter to $262M.

Based on Tyrus Capital S.A.M.'s 13F filing for Q4 2013, filed 14 Feb 2014.